drugset / Trial / NCT01900041
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
RandomizedParallel-groupOpen-labelTreatment
Summary
Pantovigar - a high effective product designed primarily for the treatment of diffuse hair loss in women as well as for the treatment of damaged hair, in the combined therapy can be successfully applied in other types of alopecia. The purpose of this study is to evaluate efficacy and tolerability of combination therapy Pantovigar plus 2% minoxidil vs 2% minoxidil. To collect tolerability data for combined treatment Pantovigar plus 2% Minoxidil course therapy.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-05
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pantovigar | Unknown | — | Oral |
| Background | Minoxidil | Small molecule | 1 ml | Topical |
| Background | Minoxidil | Small molecule | 2 % | Topical |